BETA-聚葡萄糖產品市場：依原料、等級及地區分類

Beta Glucan Based Products Market, By Source, By Grade, By Geography

出版日期: 2026年01月28日 | 出版商:

Coherent Market Insights | 英文 133 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026 年 BETA-聚葡萄糖產品的市場規模估計為 7.1 億美元，預計到 2033 年將達到 12.5 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 9.8%。

報告內容		報告詳情
基準年：	2025	2026年市場規模：	7.1億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
預測期（2026-2033年）複合年成長率：	9.80%	2033 年的預測值：	12.5億美元

BETA-聚葡萄糖是膳食纖維的重要組成部分，可從燕麥、大麥、細菌和酵母中提取。它具有多種生理作用，包括降低血漿膽固醇水平、調節餐後血糖值和免疫調節作用。除了食品工業外，BETA-聚葡萄糖在製藥、醫療、化妝品和工業領域以及最終產品製造的應用也日益廣泛。

BETA-聚葡萄糖具有調節免疫系統和降低血糖值的作用，因此可能成為治療糖尿病的潛在藥物。它們還能透過降低膽固醇水平來預防心臟病發作，並具有抗腫瘤作用。在醫學上，BETA-聚葡萄糖被用於治療多種疾病，包括高膽固醇症、糖尿病、癌症和愛滋病。

市場動態

BETA-葡聚醣作為一種潛在活性成分，在食品、醫療、製藥、動物飼料和工業等領域的應用日益廣泛，預計將導致對BETA-葡聚醣的需求增加，從而在不久的將來推動市場成長。此外，BETA-葡聚醣的健康益處，以及全球消費者對營養食品和膳食補充劑的偏好不斷變化，預計也將推動市場成長。

此外，主要市場參與者正致力於採取各種策略來獲取更大的市場佔有率，這也有望促進市場成長。例如，2017年4月，凱敏工業公司（Kemin Industries）從總部位於美國普利茅斯的Algal Scientific公司收購了BETA-葡聚醣生產技術。此外，2014年10月，Nutra-Q公司宣布與美國國際化學公司（AIC）建立銷售合作夥伴關係，由AIC在美國、加拿大和墨西哥獨家銷售NBG系列BETA-葡聚醣產品。

本次調查的主要特點

本報告對BETA-聚葡萄糖產品市場進行了詳細分析，以2025年為基準年，給出了預測期（2026-2033年）內的市場規模和複合年成長率（%）。
它還重點介紹了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
該研究還提供了有關脊椎管理產品的市場促進因素、限制因素、機會、核准和上市、區域前景以及主要企業採取的競爭策略的重要見解。
該報告根據以下參數對全球BETA-聚葡萄糖產品市場的主要企業進行了分析：公司概況、財務業績、產品系列、地理擴張、分銷策略、關鍵發展和策略以及未來計劃。
本報告的研究結果將有助於負責人和企業經營團隊就即將推出的產品、製造設施升級、市場擴張和行銷策略做出明智的決策。
這份全球BETA-聚葡萄糖產品市場報告針對產業內的各種相關人員，包括投資者、供應商、BETA-聚葡萄糖產品製造商、經銷商、新參與企業和金融分析師。
相關人員將能夠透過用於分析BETA-聚葡萄糖產品市場的各種策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第7章競爭情勢

Jkosmmune
Lesaffre Group
Garuda International, Inc.
Ohly GmBH
Koninklijke DSM NV
Kerry Group PLC
STR Biotech Co. Ltd.
Macrocare Tech Co., Ltd.
Amarte USA, LLC
Ceapro Inc.
Biotec Pharmacon ASA
Quegen Biotech Co., Ltd.
Kemin Industries, Inc.
NutraQ AS
Lantmannen
Carbon Medical Technologies, Inc.
Givaudan SA
Danaher Corporation
Super Beta Glucan Inc.
AIPPO

第8章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第9章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI2597

Beta Glucan Based Products Market is estimated to be valued at USD 710 Mn in 2026 and is expected to reach USD 1,250 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 710 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.80%	2033 Value Projection:	USD 1,250 Mn

Beta glucan is an important component of dietary fiber, which can be extracted from oat, barley, bacteria, and yeast. It possesses several physiological effects, including lowering plasma cholesterol level, control of postprandial glucose level, and immune modulation effects. Apart from the food industry, beta glucan is increasingly being used in the pharmaceutical, medical, cosmetic, and industrial applications, and end product manufacturing.

Beta glucans can act as an immune system modulator and also has the ability to reduce blood glucose, and it may be used in the treatment of diabetes mellitus. Beta glucans can protect the body from heart attack by lowering cholesterol levels and it also acts as an anti-tumor agent. Beta glucans are used in medical field to treat various diseases including hyper cholesterolemia, diabetes, cancer, and HIV/AIDS.

Market Dynamics

Increasing applications of beta glucan as potential active ingredient in various food, medical, pharmaceutical, animal feed, and industrial applications is expected to increase demand for beta glucan and this is expected to aid in growth of the market in the near future. Moreover, health benefits of beta glucan along with changing consumer preferences towards use of nutritious food and dietary supplements among global population is expected to propel the market growth.

Furthermore, key players in the market are focusing on gaining significant market share by adopting various strategies and this is expected to aid in the market growth. For instance, in April 2017, Kemin Industries acquired a beta-glucan manufacturing technology from Algal Scientific, a company headquartered in Plymouth, U.S. In October 2014, NutraQ announced that it entered into a distribution partnership with American International Chemical LLC (AIC) to exclusively distribute NBG range of beta-glucans in in the U.S., Canada, and Mexico.

Key features of the study

This report provides in-depth analysis of beta glucan based products market and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
This study also provides key insights into market drivers, restraints, opportunities, scoliosis management product approval & launch, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global beta glucan based products market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as part of this study include Jkosmmune, Lesaffre Group, Merck KGaA, Garuda International, Inc., Ohly GmBH, Koninklijke DSM N.V., Kerry Group PLC, STR Biotech Co. Ltd., Macrocare Tech Co., Ltd., Amarte USA, LLC, Ceapro Inc., Biotec Pharmacon ASA, Quegen Biotech Co., Ltd., Kemin Industries, Inc., NutraQ AS, Lantmannen, Carbon Medical Technologies, Inc., Givaudan SA, Danaher Corporation, Super Beta Glucan Inc., and AIPPO
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, manufacturing up-gradation, market expansion, and marketing tactics
The global beta glucan based products market report caters to various stakeholders in this industry including investors, suppliers, beta glucan based product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the beta glucan based products market

Market Segmentation

Source Insights (Revenue, USD Mn, 2026 - 2033)
- Cereals
- Yeast
- Mushroom
- Others
Grade Insights (Revenue, USD Mn, 2026 - 2033)
- Pharma
- Medical
- Food
- Cosmetics
- Enhanced Oil Recovery
- Animal Feed
Regional Insights (Revenue, USD Mn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
Key Players Insights
- Jkosmmune
- Lesaffre Group
- Garuda International, Inc.
- Ohly GmbH
- Koninklijke DSM N.V.
- Kerry Group PLC
- STR Biotech Co. Ltd.
- Macrocare Tech Co., Ltd.
- Amarte USA, LLC
- Ceapro Inc.
- Biotec Pharmacon ASA
- Quegen Biotech Co., Ltd.
- Kemin Industries, Inc.
- NutraQ AS
- Lantmannen
- Carbon Medical Technologies, Inc.
- Givaudan SA
- Danaher Corporation
- Super Beta Glucan Inc.
- AIPPO

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Global Beta Glucan Based Products Market, By Source
- Global Beta Glucan Based Products Market, By Grade
- Global Beta Glucan Based Products Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trend

4. Global Beta Glucan Based Products Market, By Source, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Cereals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Yeast
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Mushroom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Beta Glucan Based Products Market, By Grade, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Pharma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Medical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Food
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Cosmetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Enhanced Oil Recovery (EOR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Animal Feed
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Beta Glucan Based Products Market, By Region, 2026 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Source, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Grade, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Jkosmmune
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lesaffre Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Garuda International, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ohly GmBH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Koninklijke DSM N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kerry Group PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
STR Biotech Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Macrocare Tech Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amarte USA, LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ceapro Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biotec Pharmacon ASA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Quegen Biotech Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kemin Industries, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NutraQ AS
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lantmannen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Carbon Medical Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Givaudan SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Super Beta Glucan Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AIPPO
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies